Hashimoto’s thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer

  1. Antongiulio Faggiano3
  1. 1Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy
  2. 2IOS & COLEMAN Srl, Naples, Italy
  3. 3Thyroid and Parathyroid Surgery Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori-IRCCS ‘Fondazione G. Pascale’, Naples, Italy
  4. 4Department of Anesthesiologic, Surgical and Emergency Sciences, Division of General and Oncologic Surgery, University of Campania Luigi Vanvitelli, Naples, Italy
  5. 5Department of Public Health, University of Naples ‘Federico II,’, Naples, Italy
  6. 6San Giovanni di Dio e Ruggi D’Aragona, Universitary Hospital, Division of General Surgery, University of Salerno, Salerno, Italy
  7. 7Department of Pathology, Istituto Nazionale per lo Studio e la Cura dei Tumori-IRCCS ‘Fondazione G. Pascale’, Naples, Italy
  8. 8Dipartimento Chirurgico Generale e Polispecialistico, Chirurgia 2, AORN Cardarelli, Naples, Italy
  9. 9Dipartimento di Scienze Chirurgiche, Università di Roma Sapienza, Roma, Italy
  1. Correspondence should be addressed to V Marotta; Email: vinc.endo{at}libero.it
  1. Figure 1

    Kaplan–Meier analysis of recurrence-free survival according to co-existing HT. HT, Hashimoto’s thyroiditis.

| Table of Contents